Table 7.
Prognostic characteristics of survival in subjects with Malignant pleural effusions.
| Variables | Hazard ratio | 95% confidence intervals | p | |
|---|---|---|---|---|
| Age | 72 (67–81) | 1.015 | 0.9885–1.043 | ns |
| Female sex | 36 (32) | 1.092 | 0.5813–1.964 | ns |
| Smoking | 84 (76) | 0.97 | 0.4792–1.941 | ns |
| Unilateral/Bilateral PE | 92 (83)/19 (17) | 3.49 | 1.700–6.969 | 0.0005 |
| Small/moderate/large PE | 25 (22)/44 (40)/42 (38) | 0.76 | 0.4613–1.253 | ns |
| APACHE II score | 10 (5–15) | 1.06 | 1.005–1.125 | 0.035 |
| SOFA score | 2 (1–3) | 0.86 | 0.6845–1.056 | ns |
| CCI | 4 (4–5) | 1.12 | 0.9076–1.385 | ns |
| In-hospital days | 8 (5–15) | |||
| Survival days from diagnosis | 100 (39–339) |
Continuous variables are presented as median (interquartile range) and categorical outcomes as absolute n (% frequency). Survival analysis is performed using Cox proportional hazards regression (significant p < 0.05). PE, pleural effusion; APACHE II, acute physiology and chronic health evaluation; SOFA, sequential organ failure assessment; CCI, Charlson comorbidity index.